Physician profile
Eguono Maples
NPI 1568874220
$658.85
in general payments reported to CMS, 2019-2025
9 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $33.57 · 2024: $329 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.86 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $188.44 | 2024-2025 | Monjuvi, Jakafi |
| Janssen Biotech, INC. | $139.76 | 2024-2025 | Tecvayli, Darzalex, Talvey |
| Lilly USA, LLC | $96.95 | 2023-2024 | Jaypirca |
| Abbvie INC. | $65.79 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $61.71 | 2025 | Calquence |
| Sobi, INC | $34.21 | 2025 | |
| Adc Therapeutics America, INC. | $31.92 | 2024 | |
| Genmab U.S., INC. | $22.72 | 2024 | Epkinly |
| Karyopharm Therapeutics INC. | $17.35 | 2024 | Xpovio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eguono Maples listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.